Ketone Supplementation in Eating Disorders
Key facts
- Who runs it
- University of California, San Diego
- Where
- San Diego, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 38 people enrolled
- Started
- 13 Oct 2022
- Ended
- 6 Jul 2026
- Type of study
- Interventional
- Treatments tested
- Kenetik Ketone Drink
- Record updated
- 3 August 2026
Who can take part
- Age
- 18 years to 65 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Must currently meet DSM-5 criteria for Anorexia Nervosa, Bulimia Nervosa, or OSFED Anorexia or Bulimia Nervosa based on the MINI diagnostic interview
- Be medically stable as assessed by a comprehensive medical and behavioral evaluation conducted by a study physician
- English as primary spoken language
- Ability to respond to EMA questions up to 6x per day within 60 minutes of receiving the message
Who cannot take part
- Psychotic illness/other organic brain syndromes, dementia, somatization disorders or conversion disorders
- Physical conditions (e.g., diabetes mellitus, pregnancy) known to influence eating or weight
- Medical conditions associated with ketoacidosis: type 1 diabetes mellitus, acute pancreatitis, alcoholic gastritis, peptic ulcer disease, hepatitis or Boerhaave syndrome (esophageal rupture)
- History of significant head trauma
- Indication of intellectual disability or autism spectrum disorder
- Known allergy to any of the KenetikR drink components: D-beta-hydroxybutyric acid (D-BHB), Stevia, Monkfruit, Potassium Bicarbonate, Sodium Bicarbonate Potassium Sorbate or Taste Task Solutions: Sucrose, Potassium Chloride, Sodium bicarbonate
- Current substance abuse or dependence in the past 3 months
Where in United States
- University of California San DiegoSan Diego, United States
About the trial
What the trial wants to find out
This study will investigate the effects of ketone supplementation on eating behavior including drive to binge eat or restrict, mood and anxiety in individuals with anorexia or bulimia nervosa. In addition, the investigators will contrast the effects of active ketone supplementation versus placebo on electroencephalogram (EEG) measurement. All subjects enrolled in the study will undergo EEG on two consecutive days at the beginning of the study, after active ketone supplementation or placebo drink, matched in taste to the ketone drink. Days will be randomized. Thereafter, all subjects will take the ketone supplementation drink for two weeks, twice daily.
The group in the trial
- Ketone SupplementationTreatment being tested
Subjects will ingest 2 daily doses of Kenetik ketone drink supplementation for 14 days.
Treatment: Kenetik Ketone Drink
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Starving for Energy - A Pilot Study to Test Ketone Derived Energy in Eating Disorders
- Record updated
- 3 August 2026